Animal Healthcare Market (Animal Type: Bovine, Porcine, Ovine, and Poultry; Therapeutic Type: Drugs and Vaccines) - India Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Companies Mentioned
Other prominent players
IDEXX Laboratories, Inc.
Virbac SA
Boehringer Ingelheim GmbH
Merial Ltd.
Ceva Sante Animale
Merck & Co. Inc.
Elanco Products Company
Bayer AG
Countries
India
Forecast Year (first) - 2022
Forecast Year (last) - 2031
Forecast Year ( first) Value - 869.54
Forecast Year (last) Value - 1.36
CAGR % - 0.069
Currency - US$ Mn
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: India Animal Healthcare Market
- 4. Market Overview
- 4.1. Introduction
- 4.1.1. Animal Type Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. India Animal Healthcare Market Analysis and Forecast, 2017–2031
- 4.4.1. Market Revenue Projections (US$ Mn)
- 5. Key Insights
- 5.1. Key Vendor and Distributor Analysis
- 5.2. Regulatory Scenario, by Region/Globally
- 5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
- 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
- 6. India Animal Healthcare Market Analysis and Forecast, by Animal Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Animal Type, 2017–2031
- 6.3.1. Bovine
- 6.3.2. Porcine
- 6.3.3. Ovine
- 6.3.4. Poultry
- 6.4. Market Attractiveness Analysis, by Animal Type
- 7. India Animal Healthcare Market Analysis and Forecast, by Therapeutic Type
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Therapeutic Type, 2017–2031
- 7.3.1. Drugs
- 7.3.1.1. Analgesic
- 7.3.1.2. Antipyretic
- 7.3.1.3. Anti-inflammatory
- 7.3.1.4. Others
- 7.3.2. Vaccines
- 7.3.2.1. Live Attenuated
- 7.3.2.2. Inactivated Vaccine
- 7.3.2.3. Others
- 7.4. Market Attractiveness Analysis, by Therapeutic Type
- 8. India Animal Healthcare Market Analysis and Forecast, by Distribution Channel
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Distribution Channel, 2017–2031
- 8.3.1. Veterinary Hospitals
- 8.3.2. Veterinary Clinics
- 8.3.3. Pharmacies
- 8.3.4. Others
- 8.4. Market Attractiveness Analysis, by Distribution Channel
- 9. India Animal Healthcare Market Analysis and Forecast, by Zone
- 9.1. Key Findings
- 9.2. Market Attractiveness Analysis, by Zone
- 10. India Animal Healthcare Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Animal Type, 2017–2031
- 10.2.1. Bovine
- 10.2.2. Porcine
- 10.2.3. Ovine
- 10.2.4. Poultry
- 10.3. Market Value Forecast, by Therapeutic Type, 2017–2031
- 10.3.1. Drugs
- 10.3.1.1. Analgesic
- 10.3.1.2. Antipyretic
- 10.3.1.3. Anti-inflammatory
- 10.3.1.4. Others
- 10.3.2. Vaccines
- 10.3.2.1. Live Attenuated
- 10.3.2.2. Inactivated Vaccine
- 10.3.2.3. Others
- 10.4. Market Value Forecast, by Distribution Channel, 2017–2031
- 10.4.1. Veterinary Hospitals
- 10.4.2. Veterinary Clinics
- 10.4.3. Pharmacies
- 10.4.4. Others
- 10.5. Market Value Forecast, by Zone, 2017–2031
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Animal Type
- 10.6.2. By Therapeutic Type
- 10.6.3. By Distribution Channel
- 10.6.4. By Zone
- 11. Competition Landscape
- 11.1. Market Player - Competition Matrix (by tier and size of companies)
- 11.2. Company Profiles
- 11.2.1. Bayer AG
- 11.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 11.2.1.2. Product Portfolio
- 11.2.1.3. Financial Overview
- 11.2.1.4. SWOT Analysis
- 11.2.1.5. Strategic Overview
- 11.2.2. Elanco Products Company
- 11.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 11.2.2.2. Product Portfolio
- 11.2.2.3. Financial Overview
- 11.2.2.4. SWOT Analysis
- 11.2.2.5. Strategic Overview
- 11.2.3. Merck & Co. Inc.
- 11.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 11.2.3.2. Product Portfolio
- 11.2.3.3. Financial Overview
- 11.2.3.4. SWOT Analysis
- 11.2.3.5. Strategic Overview
- 11.2.4. Ceva Sante Animale
- 11.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 11.2.4.2. Product Portfolio
- 11.2.4.3. Financial Overview
- 11.2.4.4. SWOT Analysis
- 11.2.4.5. Strategic Overview
- 11.2.5. Merial Ltd.
- 11.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 11.2.5.2. Product Portfolio
- 11.2.5.3. Financial Overview
- 11.2.5.4. SWOT Analysis
- 11.2.5.5. Strategic Overview
- 11.2.6. Boehringer Ingelheim GmbH
- 11.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 11.2.6.2. Product Portfolio
- 11.2.6.3. Financial Overview
- 11.2.6.4. SWOT Analysis
- 11.2.6.5. Strategic Overview
- 11.2.7. Virbac SA
- 11.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 11.2.7.2. Product Portfolio
- 11.2.7.3. Financial Overview
- 11.2.7.4. SWOT Analysis
- 11.2.7.5. Strategic Overview
- 11.2.8. IDEXX Laboratories, Inc.
- 11.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 11.2.8.2. Product Portfolio
- 11.2.8.3. Financial Overview
- 11.2.8.4. SWOT Analysis
- 11.2.8.5. Strategic Overview
- 11.2.9. Other prominent players
- 11.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 11.2.9.2. Product Portfolio
- 11.2.9.3. Financial Overview
- 11.2.9.4. SWOT Analysis
- 11.2.9.5. Strategic Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook